Compositions And Methods For Treatment Of Airway Hypersecretion
US Patent:
2007008, Apr 12, 2007
Filed:
Oct 10, 2006
Appl. No.:
11/545701
Inventors:
Michael Holtzman - Clayton MO, US
Assignee:
Washington University - St. Louis MO
International Classification:
A61K 48/00, A61K 39/395
US Classification:
514044000, 424145100
Abstract:
The invention relates generally to the field of treating pulmonary diseases. More specifically, the invention relates to the treatment of airway hypersecretion by the administration of an inhibitor of the epidermal growth factor receptor (EGFR) signaling pathway in combination with an inhibitor of the interleukin-13 (IL-13) signaling pathway, as well as compositions thereof.